Singaporean banks are set to report stronger profits for the fourth quarter, but growth could take a hit this year as U.S.

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private ...

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key businesses.

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...

Keith Largay joined Bain Capital’s real estate business as head of real estate capital markets, a spokesperson confirmed. It ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Taking a look at a Graham Partners-backed technology company that is pursuing a continuation vehicle funding after running a ...

Virgin Australia’s next chief executive has ruled himself out of the race before his anointment, telling Bain Capital he no ...

Avolon has settled a lawsuit against a number of insurers over jets that were prevented from leaving Russia when Western ...

According to the terms of the deal, Bain has agreed to acquire a 51 percent stake in Milacron for $287 million.

Paul Jones is the front runner in a lonely field to replace Jayne Hrdlicka. But not everyone is happy to hear he is heading ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.